Enveda Biosciences raises $130M to advance AI-driven drug discovery from natural compounds

Enveda Boisciences Inc., a biotechnology company that leverages artificial intelligence to develop new medicines, announced today that it had raised $130 million in new funding to deliver clinical catalysts across multiple programs with strong commer